Deka Bank Deutsche Girozentrale Rhythm Pharmaceuticals, Inc. Transaction History

Deka Bank Deutsche Girozentrale

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$4.3 - $30.85 $129,000 - $925,500	30,000 New	30,000 $711,000
Q4 2021 Feb 02, 2022	SELL	$8.62 - $13.9 $103,439 - $166,800	-12,000 Closed	0 $0
Q4 2020 Mar 12, 2021	SELL	$21.17 - $32.61 $12,702 - $19,566	-600 Reduced 4.76%	12,000 $357,000
Q3 2020 Oct 29, 2020	BUY	$18.13 - $30.61 $228,438 - $385,686	12,600 New	12,600 $278,000
Q3 2019 Nov 14, 2019	SELL	$18.62 - $24.51 $484,120 - $637,260	-26,000 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$21.11 - $28.48 $548,860 - $740,480	26,000 New	26,000 $564,000

189

67.1M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.18B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.